(NASDAQ: LEGN) Legend Biotech's forecast annual revenue growth rate of 52.76% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.39%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.86%.
Legend Biotech's revenue in 2024 is $455,991,000.On average, 8 Wall Street analysts forecast LEGN's revenue for 2024 to be $214,399,658,829, with the lowest LEGN revenue forecast at $198,364,544,385, and the highest LEGN revenue forecast at $232,924,765,808. On average, 8 Wall Street analysts forecast LEGN's revenue for 2025 to be $381,401,234,284, with the lowest LEGN revenue forecast at $335,401,629,880, and the highest LEGN revenue forecast at $445,938,340,945.
In 2026, LEGN is forecast to generate $604,336,500,026 in revenue, with the lowest revenue forecast at $497,345,202,930 and the highest revenue forecast at $793,443,594,860.